Detalhe da pesquisa
1.
Effects of tolvaptan discontinuation in patients with autosomal dominant polycystic kidney disease: a post hoc pooled analysis.
BMC Nephrol
; 24(1): 182, 2023 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37349694
2.
A disease progression model estimating the benefit of tolvaptan on time to end-stage renal disease for patients with rapidly progressing autosomal dominant polycystic kidney disease.
BMC Nephrol
; 23(1): 334, 2022 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36258169
3.
The societal economic burden of autosomal dominant polycystic kidney disease in the United States.
BMC Health Serv Res
; 20(1): 126, 2020 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32070341
4.
Development of the Autosomal Dominant Polycystic Kidney Disease Impact Scale: A New Health-Related Quality-of-Life Instrument.
Am J Kidney Dis
; 71(2): 225-235, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29150246
5.
Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function.
Am J Kidney Dis
; 65(6): 833-41, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25600953
6.
Patient-Reported Outcomes Measures, Polycystic Kidney Disease Burden, and Outcomes in Autosomal Dominant Polycystic Kidney Disease.
Kidney Med
; 6(1): 100755, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38192435
7.
Pain and Health-Related Quality of Life in Autosomal Dominant Polycystic Kidney Disease: Results from a National Patient-Powered Registry.
Kidney Med
; 6(5): 100813, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38689835
8.
Short-term renal hemodynamic effects of tolvaptan in subjects with autosomal dominant polycystic kidney disease at various stages of chronic kidney disease.
Kidney Int
; 84(6): 1278-86, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23903369
9.
Understanding Patients' Experiences with Borderline Personality Disorder: Qualitative Interviews.
Neuropsychiatr Dis Treat
; 19: 2115-2125, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37840625
10.
Caregiver Burden of Autosomal Dominant Polycystic Kidney Disease: A Qualitative Study.
Kidney Med
; 5(2): 100587, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36686593
11.
Tolvaptan and Kidney Function Decline in Older Individuals With Autosomal Dominant Polycystic Kidney Disease: A Pooled Analysis of Randomized Clinical Trials and Observational Studies.
Kidney Med
; 5(6): 100639, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37250503
12.
Development of a Patient-Reported Outcomes Tool to Assess Pain and Discomfort in Autosomal Dominant Polycystic Kidney Disease.
Clin J Am Soc Nephrol
; 18(2): 213-222, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36754008
13.
OVERTURE: A Worldwide, Prospective, Observational Study of Disease Characteristics in Patients With ADPKD.
Kidney Int Rep
; 8(5): 989-1001, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37180499
14.
Technical Review of Clinical Outcomes Assessments Across the Continuum of Alzheimer's Disease.
Neurol Ther
; 12(2): 571-595, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36790638
15.
Developing a Conceptual Disease Model of Patient Experiences and Identifying Patient-Reported Clinical Outcome Assessments for Use in Trials of Treatments for Focal Onset Seizures.
Neuropsychiatr Dis Treat
; 18: 611-631, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35345602
16.
Polycystic Kidney Disease-Related Disease Burden in Adolescents With Autosomal Dominant Polycystic Kidney Disease: An International Qualitative Study.
Kidney Med
; 4(3): 100415, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35386599
17.
Pooled Data Analysis of the Long-Term Treatment Effects of Tolvaptan in ADPKD.
Kidney Int Rep
; 7(5): 1037-1048, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35570988
18.
Excess healthcare costs in patients with autosomal dominant polycystic kidney disease by renal dysfunction stage.
J Med Econ
; 24(1): 193-201, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33464936
19.
Disconnect in Assessments of Autosomal Dominant Polycystic Kidney Disease Burden Between Patients and Physicians: A Survey Study.
Int J Nephrol Renovasc Dis
; 14: 105-115, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33880055
20.
Review of Clinical Outcome Assessments in Pediatric Attention-Deficit/Hyperactivity Disorder.
Neuropsychiatr Dis Treat
; 16: 1619-1643, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32669845